Exact Mass: 592.3698
Exact Mass Matches: 592.3698
Found 416 metabolites which its exact mass value is equals to given mass value 592.3698,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mesobilirubinogen
Mesobilirubinogen (also known as I-urobilinogen) is a tetrapyrrole chemical compound that is closely related to two other compounds: urobilinogen (also known as D-urobilinogen) and stercobilinogen (also known as L-urobilinogen). Specifically, urobilinogen can be reduced to form mesobilirubinogen, and mesobilirubinogen can be further reduced to form stercobilinogen. Confusingly, all three of these compounds are frequently collectively referred to as "urobilinogens". Urobilinogen is the parent compound of both stercobilin (the pigment that is responsible for the brown colour of feces) and urobilin (the pigment that is responsible for the yellow colour of urine). Urobilinogen is formed through the microbial degradation of its parent compound bilirubin. Urobilinogen is actually generated through the degradation of heme, the red pigment in hemoglobin and red blood cells (RBCs). RBCs have a life span of about 120 days. When the RBCs have reached the end of their useful lifespan, the cells are engulfed by macrophages and their constituents recycled or disposed of. Heme is broken down when the heme ring is opened by the enzyme known as heme oxygenase, which is found in the endoplasmic reticulum of the macrophages. The oxidation process produces the linear tetrapyrrole known as biliverdin along with ferric iron (Fe3+), and carbon monoxide (CO). In the next reaction, a second methylene group (located between rings III and IV of the porphyrin ring) is reduced by the enzyme known as biliverdin reductase, producing bilirubin. Bilirubin is significantly less extensively conjugated than biliverdin. This reduction causes a change in the colour of the biliverdin molecule from blue-green (vert or verd for green) to yellow-red, which is the colour of bilirubin (ruby or rubi for red). In plasma, virtually all the bilirubin is tightly bound to plasma proteins, largely albumin, because it is only sparingly soluble in aqueous solutions at physiological pH. In the sinusoids, unconjugated bilirubin dissociates from albumin, enters the liver cells across the cell membrane through non-ionic diffusion to the smooth endoplasmatic reticulum. In hepatocytes, bilirubin-UDP-glucuronyltransferase (bilirubin-UGT) adds 2 additional glucuronic acid molecules to bilirubin to produce the more water-soluble version of the molecule known as bilirubin diglucuronide. The bilirubin diglucuronide is transferred rapidly across the canalicular membrane into the bile canaliculi where it is then excreted as bile into the large intestine. The bilirubin is further degraded (reduced) by microbes present in the large intestine to form a colourless product known as urobilinogen. Urobilinogen that remains in the colon can either be reduced to stercobilinogen and finally oxidized to stercobilin, or it can be directly reduced to stercobilin. Some of the urobilinogen produced by the gut bacteria is reabsorbed and re-enters the enterohepatic circulation. This reabsorbed urobilinogen is oxidized and converted to urobilin. The urobilin is processed through the kidneys and then excreted in the urine, which causes the yellowish colour in urine. Urobilinogen is an uribiniloid, the product of bilirubin reduction in multiple sequential reactions. Urobilinogens are colorless chromogens that may in turn be oxidized to respective yellow oxidation products, urobilins. Under normal conditions only small amounts of bilirubin can be found in stools of adults while urobilinoids are predominant bile pigments (50-250 mg/day). Only negligible amounts of fecal urobilinoids are present in the intestinal lumen of infants during the first months of their life, due to undeveloped intestinal microflora capable of reducing bilirubin. This presumably contributes importantly to the pathogenesis of neonatal jaundice. In adults, the urobilinoid production is highly efficient. At times, it is re-excreted in the urine, where it may be later oxidized to urobilin. (PMID: 16504607) [HMDB]
nuatigenin 3-beta-D-glucopyranoside
Debromoaplysiatoxin
A member of the class of aplysiatoxins that has the structure of the parent aplysiatoxin, but is lacking the bromo substituent on the benzene ring at the position para to the phenolic hydroxy group. It is a cyanotoxin produced by several species of freshwater and marine cyanobacteria, as well as algae and molluscs. D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D002273 - Carcinogens
Agavoside A
Agavoside A is found in green vegetables. Agavoside A is from the famine food Agave american From the famine food Agave americana. Agavoside A is found in green vegetables.
Tuberoside
Tuberoside is found in mushrooms. Tuberoside is a constituent of Chinese truffles (Tuber indicum). Constituent of Chinese truffles (Tuber indicum). Tuberoside is found in mushrooms.
Avenestergenin B2
Avenestergenin B2 is found in cereals and cereal products. Aglycone from oat root. Aglycone from oat root. Avenestergenin B2 is found in cereals and cereal products.
PA(20:0/8:0)
PA(20:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/8:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/20:0)
PA(8:0/20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/20:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(10:0/i-18:0)
PA(10:0/i-18:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-18:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isooctadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/i-20:0)
PA(8:0/i-20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-20:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isoeicosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(a-13:0/a-15:0)
PA(a-13:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/a-15:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(a-13:0/i-15:0)
PA(a-13:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-15:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-12:0/i-16:0)
PA(i-12:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-16:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-13:0/a-15:0)
PA(i-13:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/a-15:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-13:0/i-15:0)
PA(i-13:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-15:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-14:0/i-14:0)
PA(i-14:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-14:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-20:0/8:0)
PA(i-20:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-20:0/8:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
1,25-Dihydroxyvitamin D3 monoglucuronide
3-(N-n-Octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolinium ethyl phosphate
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
Di-8-ANEPPS
FP-biotin
Plazomicin
3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labda-7,13E-dien-2-O-beta-[fucopyranoside-3-O-acetate]
3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labda-7,13E-dien-2-O-beta-[fucopyranoside-4-O-acetate]
3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labda-7,13E-dien-2-O-beta-[rhamnopyranoside-4-O-acetate]
7,7,8,8-Tetradehydroastaxanthin
7,8,7,8-Tetradehydroastaxanthin
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
(25S)-5alpha-spirost-20-ene-1beta,3alpha-diol 3-O-beta-D-glucopyranoside
3-(4-Hydroxybenzoyl)-1,3-Dihydroxy-14-taraxeren-28-oic acid
Neritaloside
Neritaloside is a natural product found in Mandevilla pentlandiana and Nerium oleander with data available.
3-(3,4-dihydroxyphenyl)-acrylic acid-21-(2,3-dihydroxypropoxycarbonyl)-heneicosyl ester
11,19-Di-Ac-Stigmasta-7,22-diene-2,3,5,6,9,11,19-heptol
15alpha-hydroxyfoetidinol-3-O-beta-xyloside|cimicifugoside H-6
3-O-alpha-L-Fucopyranoside-Ergosta-5,24(28)-diene-3,9,11,16-tetrol
3,3-dihydroxy-2,3,2,3-tetradehydro-beta,beta-carotene-4,4-dione|astacene|Astacin|Astacin; 3.4.3.4-Tetraketo-beta-carotin|beta,beta-carotene-3,4,3,4-tetraone|Dienon-Astacin
floribundasaponin A|pennogenin 3-O-beta-D-glucopyranoside|pennogenin-3-O-beta-D-glucopyranoside|penogenin 3-O-beta-D-glucopyranoside
(25R)-spirost-5-en-3beta,7alpha-diol-3-O-beta-D-glucopyranoside|chonglouoside SL-1
(4E)-1-(2,4-dihydroxyphenyl)-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-8-hydrox-5,9,13-trimethyl-6,9-oxo-tetradeca-4,12-diene-1-one|ferulaeone H
25-O-acetyl-3-O-[beta-L-arabinopyranosyl]cholest-5-ene-3beta,19,25-triol|junceelloside C
15alpha-benzoyloxy-3beta,11alpha,12-trihydroxyurs-12-en-24-al
3beta-acetoxy-27-(p-hydroxyl)benzoyloxylup-20(29)-en-28-oic acid
26-Sulfate-(3beta,5alpha,6beta,15alpha,16beta,24R,25R)-Stigmastane-3,5,6,15,16,25,26-heptol
25R Delta5-spirostan-1beta,3beta-diol 1-O-beta-D-galactopyranoside
5alpha-spirost-25(27)-ene-1beta,3alpha-diol 3-O-beta-D-glucopyranoside
25(R)-1beta-hydroxy-spirost-5-en-3alpha-yl O-beta-D-glucopyranoside
(24S)-ergostane-1beta,3beta,5alpha,6beta-tetraol 1,3,6-triacetate
5alpha,8alpha-epidioxy-24(R)-methylcholesta-6,22-dien-3beta-D-glucopyranoside
4-O-acetyl-3-O-[beta-D-arabinopyranosyl-oxy]-cholest-5-ene-3beta,19,25-triol|junceelloside A
3-O-acetyl-3-O-[beta-D-arabinopyranosyl-oxy]-cholest-5-ene-3beta,19,25-triol|junceelloside B
all-trans-beta-carotenetetron-(3.4.3.4)|all-trans-beta-Carotintetron-(3.4.3.4)|astacin|Astacin, 3,4,3,4-Tetraoxo-beta-carotin
2-[3-(6-acetyloxy-2-hydroxy-6-methyl-3-oxoheptan-2-yl)-6-(carboxymethyl)-2-hydroxy-3a,5a,9b-trimethyl-5-oxo-2,3,4,6,9,9a-hexahydro-1H-cyclopenta[a]naphthalen-7-yl]-2-methylpropanoic acid
Gallinamide A
D000890 - Anti-Infective Agents > D023181 - Antimicrobial Cationic Peptides
2-[3-(6-acetyloxy-2-hydroxy-6-methyl-3-oxoheptan-2-yl)-6-(carboxymethyl)-2-hydroxy-3a,5a,9b-trimethyl-5-oxo-2,3,4,6,9,9a-hexahydro-1H-cyclopenta[a]naphthalen-7-yl]-2-methylpropanoic acid [IIN-based: Match]
UROBILINOGEN
A member of the class of bilanes that is a colourless product formed in the intestine by the reduction of bilirubin.
Phe Ile Lys Trp
Phe Ile Trp Lys
Phe Lys Ile Trp
Phe Lys Leu Trp
Phe Lys Trp Ile
Phe Lys Trp Leu
Phe Leu Lys Trp
Phe Leu Trp Lys
Phe Trp Ile Lys
Phe Trp Lys Ile
Phe Trp Lys Leu
Phe Trp Leu Lys
Ile Phe Lys Trp
Ile Phe Trp Lys
Ile Lys Phe Trp
Ile Lys Trp Phe
Ile Trp Phe Lys
Ile Trp Lys Phe
Lys Phe Ile Trp
Lys Phe Leu Trp
Lys Phe Trp Ile
Lys Phe Trp Leu
Lys Ile Phe Trp
Lys Ile Trp Phe
Lys Leu Phe Trp
Lys Leu Trp Phe
Lys Trp Phe Ile
Lys Trp Phe Leu
Lys Trp Ile Phe
Lys Trp Leu Phe
Leu Phe Lys Trp
Leu Phe Trp Lys
Leu Lys Phe Trp
Leu Lys Trp Phe
Leu Trp Phe Lys
Leu Trp Lys Phe
Arg Arg Val Tyr
Arg Arg Tyr Val
Arg Val Arg Tyr
Arg Val Tyr Arg
Arg Tyr Arg Val
Arg Tyr Val Arg
Val Arg Arg Tyr
Val Arg Tyr Arg
Val Tyr Arg Arg
Trp Phe Ile Lys
Trp Phe Lys Ile
Trp Phe Lys Leu
Trp Phe Leu Lys
Trp Ile Phe Lys
Trp Ile Lys Phe
Trp Lys Phe Ile
Trp Lys Phe Leu
Trp Lys Ile Phe
Trp Lys Leu Phe
Trp Leu Phe Lys
Trp Leu Lys Phe
Tyr Arg Arg Val
Tyr Arg Val Arg
Tyr Val Arg Arg
Dimyristoyl phosphatidic acid
A phosphatidic acid in which the phosphatidyl acyl groups are both myristoyl.
Dimyristoyl-sn-glycerol 3-phosphate
Dimyristoyl-sn-glycerol 3-phosphate (DMPG) is a type of phospholipid that plays a crucial role in biological systems, particularly in the structure and function of cell membranes. Here's a detailed description of its biological functions: 1. **Cell Membrane Formation**: DMPG, like other phospholipids, is a key component of cell membranes. It has a hydrophilic (water-attracting) head composed of a glycerol molecule linked to a phosphate group and two hydrophobic (water-repelling) tails made up of myristic acid chains. This amphipathic nature allows DMPG to form lipid bilayers in aqueous environments, which is the basic structure of cell membranes. 2. **Membrane Fluidity**: The presence of myristic acid chains in DMPG contributes to the fluidity of cell membranes. The length and saturation of the fatty acid tails influence how tightly packed the phospholipids are in the membrane. Myristic acid, being a saturated fatty acid, tends to pack more closely, which can decrease membrane fluidity. This is important for maintaining the integrity and functionality of the membrane. 3. **Signal Transduction**: Phospholipids, including DMPG, are involved in signal transduction pathways within cells. Changes in the concentration or distribution of phospholipids can affect the activity of membrane-bound proteins, such as enzymes and receptors, which are critical for cellular signaling. 4. **Biosynthesis of Other Lipids**: DMPG serves as a precursor for the synthesis of other important lipids in the cell. For example, it can be converted into other types of phospholipids or used in the synthesis of complex lipids like sphingolipids. 5. **Role in Vesicular Transport**: In cells, DMPG is involved in the formation of transport vesicles that carry molecules within the cell and to the cell membrane. This process is essential for intracellular trafficking and secretion. 6. **Potential Involvement in Disease**: Altered levels or metabolism of phospholipids, including DMPG, have been associated with various diseases, including cardiovascular diseases and cancer. Understanding the role of DMPG in these conditions can provide insights into disease mechanisms and potential therapeutic targets.
Avenestergenin B2
Tuberoside
ST 27:3;O4;Hex
ST 27:2;O3;GlcA
25,26,27,28-Tetrapropoxypentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaene
25,26,27,28-tetrahydroxy-5,11,17,23-tetrakis(1-methylethyl)calix<4>arene
Plazomicin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Di-8-ANEPPS
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
1-Hydroxy-3-((4-hydroxybenzoyl)oxy)-D-friedoolean-14-en-28-oic acid (1beta,3beta)-
(6R)-6-[(1R,3aS,4E,7aR)-4-{(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyloctahydro-1H-inden-1-yl]-2-methylheptan-2-yl beta-D-glucopyranosiduronic acid
(1r)-2-(Phosphonooxy)-1-[(Tridecanoyloxy)methyl]ethyl Pentadecanoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] octadecanoate
17-Debromoaplysiatoxin
D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D002273 - Carcinogens
6-[(3Z)-3-[(2E)-2-[7a-methyl-1-(6-methylheptan-2-yl)-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexyl]oxy-3,4,5,6-tetrahydroxyoxane-2-carboperoxoic acid
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
floribundasaponin A
A spirostanyl glycoside that is pennogenin attached to a beta-D-glucopyranosyl moiety at position 3 via a glycosidic linkage. Isolated from the stem bark of Dracaena mannii, it exhibits anti-inflammatory activity.
(2R)-1-(decanoyloxy)-3-(phosphonooxy)propan-2-yl octadecanoate
4-(dimethylamino)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4-(dimethylamino)-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
2-[[(2R)-2-butanoyloxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-3-hydroxy-2-[(Z)-7-[(1R,4S,5R,6R)-6-[(E,3S)-3-hydroxyoct-1-enyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-3-hydroxy-2-[(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (13Z,16Z)-tetracosa-13,16-dienoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) docosanoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) pentacosanoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) hexacosanoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
(1-Octanoyloxy-3-phosphonooxypropan-2-yl) icosanoate
(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate
(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate
(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) pentadecanoate
(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) heptadecanoate
(1-Decanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate
2-[3-(6-acetyloxy-2-hydroxy-6-methyl-3-oxoheptan-2-yl)-6-(carboxymethyl)-2-hydroxy-3a,5a,9b-trimethyl-5-oxo-2,3,4,6,9,9a-hexahydro-1H-cyclopenta[a]naphthalen-7-yl]-2-methylpropanoic acid
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] heptadecanoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] heptadecanoate
[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate
2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-butanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-acetyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-heptanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
agavoside A
A steroid saponin that consists of (25R)-5alpha-spirostan-3beta-ol substituted by an oxo group at position 12 and a beta-D-galactopyranosyl moiety at position 3 via a glycosidic linkage.
1beta-hydroxymaprounic acid 3-p-hydroxybenzoate
A pentacyclic triterpenoid that is the benzoate ester obtained by the condensation of the 3-hydroxy group of 1beta-hydroxymaprounic acid with p-hydroxybenzoic acid. Isolated from Maprounea africana, it exhibits inhibitory activity against HIV-1 reverse transcriptase.
1-decanoyl-2-stearoyl-sn-phosphatidic acid
A 1,2-diacyl-sn-glycerol 3-phosphate (sn-phosphatidic acid) in which the acyl groups at positions 1 and 2 are specified as decanoyl and stearoyl respectively.
calcitriol 25-O-(beta-D-glucuronide)
A steroid glucosiduronic acid that is calcitriol in which the hydroxy hydrogen at position 25 has been replaced by a beta-D-glucuronyl residue.
1,2-ditetradecanoyl-sn-glycerol-3-phosphate
A 1-acyl-2-tetradecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as tetradecanoyl (myristoyl).
LCL521
LCL521 is an acid ceramidase (ACDase) inhibitor. LCL521 also inhibits the lysosomal acid sphingomyelinase (ASMase)[1].
